Patents by Inventor Junling Li

Junling Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for treating cancer and diagnostic assays for use therein
    Patent number: 8624027
    Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: January 7, 2014
    Assignee: AbbVie Inc.
    Inventors: Omar Jameel Shah, Yu Shen, Xiaoyu Lin, Mark Anderson, Xiaoli Huang, Junling Li, Leiming Li
  • Combination Therapy for Treating Cancer and Diagnostic Assays for Use Therein
    Publication number: 20100227838
    Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
    Type: Application
    Filed: December 4, 2009
    Publication date: September 9, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Omar Jameel Shah, Yu Shen, Xiaoyu Lin, Mark Anderson, Xiaoli Huang, Junling Li, Leiming Li
  • Antisense modulation of histone deacetylase 4 expression
    Publication number: 20040077084
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Histone deacetylase 4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Histone deacetylase 4. Methods of using these compounds for modulation of Histone deacetylase 4 expression and for treatment of diseases associated with expression of Histone deacetylase 4 are provided.
    Type: Application
    Filed: October 17, 2002
    Publication date: April 22, 2004
    Applicants: Isis Pharmaceuticals Inc., Abbott Laboratories
    Inventors: Andrew T. Watt, Steven Davidsen, Junling Li, Keith Glaser